| Blueprint Medicines (Switzerland) GmbH - Gavreto 100 mg, Hartkapseln | | 68182 | | 01 | | Gavreto 100 mg | | Hartkapseln | | L01EX | | Other Protein Kinase Inhibitors | | 12.08.2021 | | |
| | Composition | | pralsetinibum 100 mg, hypromellosum, cellulosum microcristallinum, natrii hydrogenocarbonas corresp. natrium 22.3 mg, acidum citricum, magnesii stearas, amylum pregelificatum, Kapselhülle: hypromellosum, E 171, E 133, Drucktinte: lacca, propylenglycolum, ammonii hydroxidum, kalii hydroxidum, E 171, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Pralsetinibum | 100 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Pralsetinibum | 100 mg |
| | | | Agents auxilliaires | | informations additionels |
|---|
| Acide Citrique | | | | Ammonii Hydroxidum | | | | Amylum Pregelificatum | | | | Cellulosum Microcristallinum | | | | E 133 | | color. | | E 171 | | color. | | Hypromellosum | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Sodium Hydrogenocarbonate | | | | Pro Capsula | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 120 | 5969.33 | 6432.35 | A | | Oui |
|
|
